Mitotic rate is associated with positive lymph nodes in patients with thin melanomas

被引:23
作者
Wheless, Lee [1 ]
Isom, Chelsea A. [2 ]
Hooks, Mary A. [2 ]
Kauffmann, Rondi M. [2 ]
机构
[1] Vanderbilt Univ, Med Ctr, Dept Dermatol, Nashville, TN USA
[2] Vanderbilt Univ, Dept Surg, Med Ctr, Div Surg Oncol & Endocrine Surg, Nashville, TN 37240 USA
关键词
clinical research; guidelines; melanoma; mitotic rate; skin cancer; staging; PRIMARY CUTANEOUS MELANOMA; AMERICAN JOINT COMMITTEE; BIOPSY; THICKNESS; 10-YEAR; INSTITUTION; POPULATION; DATABASE; TRENDS;
D O I
10.1016/j.jaad.2017.11.041
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: The American Joint Commission on Cancer will remove mitotic rate from its staging guidelines in 2018. Objective: Using a large nationally representative cohort, we examined the association between mitotic rate and lymph node positivity among thin melanomas. Methods: A total of 149,273 thin melanomas in the National Cancer Database were examined for their association of high-risk features of mitotic rate, ulceration, and Breslow depth with lymph node status. Results: Among 17,204 patients with thin melanomas with data on Breslow depth, ulceration, and mitotic rate who underwent a lymph node biopsy, there was a strong linear relationship between odds of having a positive lymph node andmitotic rate (R-2=0.96, P<.0001, beta=3.31). The odds of having a positive node increased by 19% with each 1-point increase in mitotic rate (odds ratio, 1.19; 95% confidence interval, 1.17-1.21). Cases with negative nodes had a mean mitotic rate of 1.54 plus or minus 2.07 mitoses/mm(2) compared with 3.30 plus or minus 3.54 mitoses/mm(2) for those with positive nodes (P<.0001). Limitations: The data collected do not allow for survival analyses. Conclusions: Mitotic rate was strongly associated with the odds of having a positive lymph node and should continue to be reported on pathology reports.
引用
收藏
页码:935 / 941
页数:7
相关论文
共 33 条
[1]   Melanoma incidence and Breslow tumour thickness development in the central Alpine region of South Tyrol from 1998 to 2012: a population-based study [J].
Ambrosini-Spaltro, A. ;
Dal Cappello, T. ;
Deluca, J. ;
Carriere, C. ;
Mazzoleni, G. ;
Eisendle, K. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2015, 29 (02) :243-248
[2]  
Amin M.B., 2017, AM JOINT COMMITTEE C, V8th
[3]   Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma - An analysis of 3661 patients from a single center [J].
Azzola, MF ;
Shaw, HM ;
Thompson, JF ;
Soong, SJ ;
Scolyer, RA ;
Watson, GF ;
Colman, MH ;
Zhang, YT .
CANCER, 2003, 97 (06) :1488-1498
[4]   Time trends and latitudinal differences in melanoma thickness distribution in Australia, 1990-2006 [J].
Baade, Peter ;
Meng, Xingqiong ;
Youlden, Danny ;
Aitken, Joanne ;
Youl, Philippa .
INTERNATIONAL JOURNAL OF CANCER, 2012, 130 (01) :170-178
[5]   Final Version of 2009 AJCC Melanoma Staging and Classification [J].
Balch, Charles M. ;
Gershenwald, Jeffrey E. ;
Soong, Seng-jaw ;
Thompson, John F. ;
Atkins, Michael B. ;
Byrd, David R. ;
Buzaid, Antonio C. ;
Cochran, Alistair J. ;
Coit, Daniel G. ;
Ding, Shouluan ;
Eggermont, Alexander M. ;
Flaherty, Keith T. ;
Gimotty, Phyllis A. ;
Kirkwood, John M. ;
McMasters, Kelly M. ;
Mihm, Martin C., Jr. ;
Morton, Donald L. ;
Ross, Merrick I. ;
Sober, Arthur J. ;
Sondak, Vernon K. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (36) :6199-6206
[6]   Using the National Cancer Database for Outcomes Research [J].
Boffa, Daniel J. ;
Rosen, Joshua E. ;
Mallin, Katherine ;
Loomis, Ashley ;
Gay, Greer ;
Palis, Bryan ;
Thoburn, Kathleen ;
Gress, Donna ;
McKellar, Daniel P. ;
Shulman, Lawrence N. ;
Facktor, Matthew A. ;
Winchester, David P. .
JAMA ONCOLOGY, 2017, 3 (12) :1722-1728
[7]   Impact of the 2009 (7th Edition) AJCC Melanoma Staging System in the Classification of Thin Cutaneous Melanomas [J].
Chu, Vicki H. ;
Tetzlaff, Michael T. ;
Torres-Cabala, Carlos A. ;
Prieto, Victor G. ;
Bassett, Roland, Jr. ;
Gershenwald, Jeffrey E. ;
McLemore, Michael S. ;
Ivan, Doina ;
Wang, Wei-Lien ;
Ross, Merrick I. ;
Curry, Jonathan L. .
BIOMED RESEARCH INTERNATIONAL, 2013, 2013
[8]   A 10-year, single-institution analysis of clinicopathologic features and sentinel lymph node biopsy in thin melanomas [J].
Cooper, Chelsea ;
Wayne, Jeffrey D. ;
Damstetter, Elizabeth M. ;
Martini, Mary ;
Gordon, Jennifer ;
Guitart, Joan ;
West, Dennis P. ;
Nardone, Beatrice ;
Rademaker, Alfred ;
Gerami, Pedram .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 69 (05) :693-699
[9]   Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy [J].
Eggermont, A. M. M. ;
Chiarion-Sileni, V. ;
Grob, J. -J. ;
Dummer, R. ;
Wolchok, J. D. ;
Schmidt, H. ;
Hamid, O. ;
Robert, C. ;
Ascierto, P. A. ;
Richards, J. M. ;
Lebbe, C. ;
Ferraresi, V. ;
Smylie, M. ;
Weber, J. S. ;
Maio, M. ;
Bastholt, L. ;
Mortier, L. ;
Thomas, L. ;
Tahir, S. ;
Hauschild, A. ;
Hassel, J. C. ;
Hodi, F. S. ;
Taitt, C. ;
de Pril, V. ;
de Schaetzen, G. ;
Suciu, S. ;
Testori, A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (19) :1845-1855
[10]   Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma [J].
Faries, M. B. ;
Thompson, J. F. ;
Cochran, A. J. ;
Andtbacka, R. H. ;
Mozzillo, N. ;
Zager, J. S. ;
Jahkola, T. ;
Bowles, T. L. ;
Testori, A. ;
Beitsch, P. D. ;
Hoekstra, H. J. ;
Moncrieff, M. ;
Ingvar, C. ;
Wouters, M. W. J. M. ;
Sabel, M. S. ;
Levine, E. A. ;
Agnese, D. ;
Henderson, M. ;
Dummer, R. ;
Rossi, C. R. ;
Neves, R. I. ;
Trocha, S. D. ;
Wright, F. ;
Byrd, D. R. ;
Matter, M. ;
Hsueh, E. ;
MacKenzie-Ross, A. ;
Johnson, D. B. ;
Terheyden, P. ;
Berger, A. C. ;
Huston, T. L. ;
Wayne, J. D. ;
Smithers, B. M. ;
Neuman, H. B. ;
Schneebaum, S. ;
Gershenwald, J. E. ;
Ariyan, C. E. ;
Desai, D. C. ;
Jacobs, L. ;
McMasters, K. M. ;
Gesierich, A. ;
Hersey, P. ;
Bines, S. D. ;
Kane, J. M. ;
Barth, R. J. ;
McKinnon, G. ;
Farma, J. M. ;
Schultz, E. ;
Vidal-Sicart, S. ;
Hoefer, R. A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (23) :2211-2222